MATTHEW MYERS: Open Payments
NPI 1649992181 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$166 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $166
Food & beverage: $166
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $75 |
| ABBVIE INC. | 1 | $34 |
| Novo Nordisk Inc | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
Products named: QULIPTA, SHINGRIX, TRELEGY ELLIPTA, Ozempic, REXULTI, AREXVY, The Cologuard Plus Collection Kit.
Industry payments across CA — which companies pay providers there.
